Published in Trends Immunol on November 28, 2006
From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90
The myeloid cells of the central nervous system parenchyma. Nature (2010) 3.80
The pathobiology of vascular dementia. Neuron (2013) 3.07
The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol (2012) 3.07
Innate immunity in the central nervous system. J Clin Invest (2012) 2.77
B-lymphocyte-mediated delayed cognitive impairment following stroke. J Neurosci (2015) 2.31
Trafficking of immune cells in the central nervous system. J Clin Invest (2010) 2.17
The immunology of acute stroke. Nat Rev Neurol (2012) 2.06
Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity (2009) 1.95
Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev (2009) 1.90
VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J Exp Med (2009) 1.70
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Front Cell Neurosci (2013) 1.65
Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res (2011) 1.62
Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci (2015) 1.53
Effect of beta-blocker therapy on the risk of infections and death after acute stroke--a historical cohort study. PLoS One (2015) 1.49
Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials. PLoS One (2008) 1.49
Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J Virol (2007) 1.48
CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease? J Neuroimmune Pharmacol (2009) 1.43
Microglia development and function. Annu Rev Immunol (2014) 1.41
The blood-brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta (2010) 1.40
Temporal changes in cell marker expression and cellular infiltration in a controlled cortical impact model in adult male C57BL/6 mice. PLoS One (2012) 1.36
The role of inflammation in perinatal brain injury. Nat Rev Neurol (2015) 1.35
Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity. Int J Environ Res Public Health (2011) 1.27
Monocytes regulate T cell migration through the glia limitans during acute viral encephalitis. J Virol (2010) 1.27
Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation. J Leukoc Biol (2008) 1.25
Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin Immunopathol (2013) 1.24
Experimental approaches for the treatment of malignant gliomas. Pharmacol Ther (2010) 1.23
Pathogenesis of central nervous system tuberculosis. Curr Mol Med (2009) 1.22
Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis (2009) 1.22
Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimers Res Ther (2010) 1.20
The role of dendritic cells in CNS autoimmunity. J Mol Med (Berl) (2010) 1.19
Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome. J Infect Dis (2013) 1.18
The adaptive immune system in diseases of the central nervous system. J Clin Invest (2012) 1.17
Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors. Neuro Oncol (2008) 1.15
Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology (2007) 1.13
Bone marrow cell recruitment to the brain in the absence of irradiation or parabiosis bias. PLoS One (2013) 1.12
Dysregulated neuronal-microglial cross-talk during aging, stress and inflammation. Exp Neurol (2010) 1.12
Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders. Brain Behav Immun (2010) 1.11
Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment. Expert Opin Drug Metab Toxicol (2008) 1.11
Immune privilege of the CNS is not the consequence of limited antigen sampling. Sci Rep (2014) 1.09
Aquaporin 4: a player in cerebral edema and neuroinflammation. J Neuroinflammation (2012) 1.09
The ischemic environment drives microglia and macrophage function. Front Neurol (2015) 1.09
Immunity and inflammation in neurodegenerative diseases. Am J Neurodegener Dis (2013) 1.08
Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior. Front Neurosci (2015) 1.08
Development of histocompatible primate-induced pluripotent stem cells for neural transplantation. Stem Cells (2011) 1.07
Immunology: In the beginning. Nature (2009) 1.06
Gene transfer into rat brain using adenoviral vectors. Curr Protoc Neurosci (2010) 1.05
The scoop on the fly brain: glial engulfment functions in Drosophila. Neuron Glia Biol (2007) 1.05
Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas. Nanomedicine (2009) 1.04
The pathological and physiological roles of IL-6 amplifier activation. Int J Biol Sci (2012) 1.03
Engraftment of human nasal olfactory stem cells restores neuroplasticity in mice with hippocampal lesions. J Clin Invest (2011) 1.01
Autophagy in inflammation, infection, neurodegeneration and cancer. Int Immunopharmacol (2013) 1.00
Mevalonate kinase deficiency and neuroinflammation: balance between apoptosis and pyroptosis. Int J Mol Sci (2013) 1.00
Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases. J Neuroinflammation (2012) 0.99
Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis. J Neuroinflammation (2008) 0.98
Intracellular and circulating neuronal antinuclear antibodies in human epilepsy. Neurobiol Dis (2013) 0.98
Role of Mycobacterium tuberculosis pknD in the pathogenesis of central nervous system tuberculosis. BMC Microbiol (2012) 0.98
Heterogeneity of microglia and TNF signaling as determinants for neuronal death or survival. Neurotoxicology (2009) 0.98
Common variation in genes related to innate immunity and risk of adult glioma. Cancer Epidemiol Biomarkers Prev (2009) 0.96
Innate inflammation in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 0.96
Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved. Curr Opin Pharmacol (2008) 0.96
Brain dendritic cells: biology and pathology. Acta Neuropathol (2012) 0.96
Toll-like receptors are key players in neurodegeneration. Int Immunopharmacol (2011) 0.95
Multimodal investigations of trans-endothelial cell trafficking under condition of disrupted blood-brain barrier integrity. BMC Neurosci (2010) 0.95
Brain-reactive antibodies and disease. Annu Rev Immunol (2013) 0.94
Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy. Neuropharmacology (2010) 0.94
Activity of T-DM1 in Her2-positive breast cancer brain metastases. Clin Exp Metastasis (2015) 0.94
Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection. PLoS Pathog (2011) 0.94
Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas. Curr Gene Ther (2009) 0.94
Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis. J Neuroinflammation (2012) 0.94
The central role of aquaporins in the pathophysiology of ischemic stroke. Front Cell Neurosci (2015) 0.93
Implications of glial nitric oxide in neurodegenerative diseases. Front Cell Neurosci (2015) 0.93
Neuroinflammation: Ways in Which the Immune System Affects the Brain. Neurotherapeutics (2015) 0.93
Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures. Epilepsia (2011) 0.93
High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types. Ann Clin Transl Neurol (2014) 0.93
Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers. Front Cell Neurosci (2014) 0.92
Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases. Oncoimmunology (2015) 0.92
Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain. Aging Dis (2010) 0.92
The role of host genetics in the susceptibility for HIV-associated neurocognitive disorders. AIDS Behav (2008) 0.91
S100B attenuates microglia activation in gliomas: possible role of STAT3 pathway. Glia (2010) 0.90
In situ activation of antigen-specific CD8+ T cells in the presence of antigen in organotypic brain slices. J Immunol (2008) 0.90
Brain transcriptome sequencing and assembly of three songbird model systems for the study of social behavior. PeerJ (2014) 0.90
CD11b+GR1+ myeloid cells secrete NGF and promote trigeminal ganglion neurite growth: implications for corneal nerve regeneration. Invest Ophthalmol Vis Sci (2013) 0.90
Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age-related macular degeneration. EMBO Mol Med (2015) 0.89
HIV-1 target cells in the CNS. J Neurovirol (2014) 0.89
The movers and shapers in immune privilege of the CNS. Nat Immunol (2017) 0.88
Peripheral dendritic cells are essential for both the innate and adaptive antiviral immune responses in the central nervous system. Virology (2009) 0.88
MicroRNAs as novel regulators of neuroinflammation. Mediators Inflamm (2013) 0.88
Intracerebral CpG immunotherapy with carbon nanotubes abrogates growth of subcutaneous melanomas in mice. Clin Cancer Res (2012) 0.88
Combating immunosuppression in glioma. Future Oncol (2008) 0.87
The HIV-1 transgenic rat model of neuroHIV. Brain Behav Immun (2015) 0.87
Gadofluorine M-enhanced MRI shows involvement of circumventricular organs in neuroinflammation. J Neuroinflammation (2010) 0.87
Targeting tumor suppressor networks for cancer therapeutics. Curr Drug Targets (2014) 0.87
Immune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammation. Mediators Inflamm (2013) 0.86
Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology. Proc Natl Acad Sci U S A (2010) 0.86
Poly(I:C) promotes TNFα/TNFR1-dependent oligodendrocyte death in mixed glial cultures. J Neuroinflammation (2011) 0.86
Stroke patients develop antibodies that react with components of N-methyl-D-aspartate receptor subunit 1 in proportion to lesion size. Stroke (2013) 0.86
Alzheimer's disease, neuroprotection, and CNS immunosenescence. Front Pharmacol (2012) 0.86
Is peripheral immunity regulated by blood-brain barrier permeability changes? PLoS One (2014) 0.85
Tolerance to the neuron-specific paraneoplastic HuD antigen. PLoS One (2009) 0.85
Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol (2009) 6.79
Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J (2002) 3.81
Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci (2005) 3.33
Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci (2004) 3.17
TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain (2006) 2.80
Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat Med (2006) 2.72
Sickle hemoglobin confers tolerance to Plasmodium infection. Cell (2011) 2.67
Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry (2008) 2.66
What is the blood-brain barrier (not)? Trends Immunol (2006) 2.42
Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci (2002) 2.40
Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J Neurosci (2011) 2.31
Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol (2009) 2.09
Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J (2005) 2.04
Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. Neuron (2005) 2.01
TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia (2008) 1.97
The perfect crime? CCSVI not leaving a trace in MS. J Neurol Neurosurg Psychiatry (2011) 1.96
Migration of monocytes after intracerebral injection at entorhinal cortex lesion site. J Leukoc Biol (2012) 1.93
Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Metab (2002) 1.88
An antigen-specific pathway for CD8 T cells across the blood-brain barrier. J Exp Med (2007) 1.84
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain (2003) 1.82
Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J (2009) 1.82
A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J Immunol (2006) 1.76
Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med (Berl) (2006) 1.73
Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation. Nat Neurosci (2013) 1.62
Regulation of microglial proliferation during chronic neurodegeneration. J Neurosci (2013) 1.59
CNS pericytes: concepts, misconceptions, and a way out. Glia (2010) 1.59
CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci (2004) 1.57
Local type I IFN receptor signaling protects against virus spread within the central nervous system. J Immunol (2009) 1.57
Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol (2008) 1.52
Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet (2013) 1.48
Assay-based response evaluation in head and neck oncology: requirements for better decision making. Eur Arch Otorhinolaryngol (2010) 1.44
Mannose receptor expression specifically reveals perivascular macrophages in normal, injured, and diseased mouse brain. Glia (2005) 1.42
Selective presynaptic degeneration in the synaptopathy associated with ME7-induced hippocampal pathology. Neurobiol Dis (2009) 1.35
Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am J Pathol (2005) 1.35
Perivascular spaces--MRI marker of inflammatory activity in the brain? Brain (2008) 1.33
Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J Clin Invest (2005) 1.32
Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am J Pathol (2004) 1.31
IDO expression in the brain: a double-edged sword. J Mol Med (Berl) (2007) 1.30
T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa. J Leukoc Biol (2006) 1.30
Association between dementia and infectious disease: evidence from a case-control study. Alzheimer Dis Assoc Disord (2005) 1.29
Adaptive responses by mouse early embryos to maternal diet protect fetal growth but predispose to adult onset disease. Biol Reprod (2007) 1.25
CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. Acta Neuropathol (2010) 1.21
Blood-brain barrier breakdown after embolic stroke in rats occurs without ultrastructural evidence for disrupting tight junctions. PLoS One (2013) 1.20
Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration. Neurobiol Dis (2007) 1.17
Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegeneration. J Immunol (2011) 1.16
Transforming growth factor-beta 1-mediated neuroprotection against excitotoxic injury in vivo. J Cereb Blood Flow Metab (2003) 1.16
Comparison of modified Thiel embalming and ethanol-glycerin fixation in an anatomy environment: Potentials and limitations of two complementary techniques. Anat Sci Educ (2014) 1.16
The repulsive guidance molecule RGMa is involved in the formation of afferent connections in the dentate gyrus. J Neurosci (2004) 1.15
Primary oligodendrocyte death does not elicit anti-CNS immunity. Nat Neurosci (2012) 1.15
Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE. J Mol Med (Berl) (2008) 1.14
Systemic inflammation induces axon injury during brain inflammation. Ann Neurol (2011) 1.13
Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. Glia (2010) 1.13
Microglial pathology. Acta Neuropathol Commun (2014) 1.13
Low protein diet fed exclusively during mouse oocyte maturation leads to behavioural and cardiovascular abnormalities in offspring. J Physiol (2008) 1.12
CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J (2003) 1.11
The systemic and local acute phase response following acute brain injury. J Cereb Blood Flow Metab (2002) 1.09
TNF-alpha reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway. Brain (2002) 1.09
Age related changes in microglial phenotype vary between CNS regions: grey versus white matter differences. Brain Behav Immun (2011) 1.09
Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain. J Neurosci (2002) 1.09
The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration. Glia (2008) 1.08
R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids. PLoS One (2010) 1.08
Pneumolysin causes neuronal cell death through mitochondrial damage. Infect Immun (2007) 1.07
NADPH oxidase Nox1 contributes to ischemic injury in experimental stroke in mice. Neurobiol Dis (2010) 1.05
TGFbeta1 regulates the inflammatory response during chronic neurodegeneration. Neurobiol Dis (2006) 1.05
Local proliferation of macrophages in adipose tissue during obesity-induced inflammation. Diabetologia (2013) 1.05
Neurites undergoing Wallerian degeneration show an apoptotic-like process with Annexin V positive staining and loss of mitochondrial membrane potential. Neurosci Res (2003) 1.04
Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia. J Neuroinflammation (2012) 1.03
Exploiting endogenous anti-apoptotic proteins for novel therapeutic strategies in cerebral ischemia. Prog Neurobiol (2008) 1.02
The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas. Clin Dev Immunol (2013) 1.01
High calorie diet triggers hypothalamic angiopathy. Mol Metab (2012) 1.01
Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease. J Virol (2005) 1.01
The persistence of paternal antigens in the maternal body is involved in regulatory T-cell expansion and fetal-maternal tolerance in murine pregnancy. Am J Reprod Immunol (2010) 0.99
Docosahexaenoic acid, but not eicosapentaenoic acid, reduces the early inflammatory response following compression spinal cord injury in the rat. J Neurochem (2012) 0.98
Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments. Neuro Oncol (2013) 0.98
Selective effects of upper respiratory tract infection on cognition, mood and emotion processing: a prospective study. Brain Behav Immun (2007) 0.97
Uncoupling protein 2 (UCP2) lowers alcohol sensitivity and pain threshold. Biochem Pharmacol (2002) 0.97
TLR2 and caspase-8 are essential for group B Streptococcus-induced apoptosis in microglia. J Immunol (2007) 0.97
Neuroprotection by T-cells depends on their subtype and activation state. J Neuroimmunol (2002) 0.96
Bone marrow-derived cells expressing green fluorescent protein under the control of the glial fibrillary acidic protein promoter do not differentiate into astrocytes in vitro and in vivo. J Neurosci (2003) 0.96
IDO (indolamine 2,3-dioxygenase) expression and function in the CNS. Adv Exp Med Biol (2003) 0.96
Altered chemokine expression in the spinal cord and brain contributes to differential interleukin-1beta-induced neutrophil recruitment. J Neurochem (2002) 0.95
Differential role of CCR2 in the dynamics of microglia and perivascular macrophages during prion disease. Glia (2014) 0.95
Retinoic acid-inducible gene-I mediates late phase induction of TNF-alpha by lipopolysaccharide. J Immunol (2008) 0.94
Failure of perivascular drainage of β-amyloid in cerebral amyloid angiopathy. Brain Pathol (2014) 0.94
Impact of stroke-associated infection on long-term survival: a cohort study. J Neurol Neurosurg Psychiatry (2012) 0.94
Expression of CXCL4 in microglia in vitro and in vivo and its possible signaling through CXCR3. J Neurochem (2008) 0.94
Regulatory T cells selectively preserve immune privilege of self-antigens during viral central nervous system infection. J Immunol (2012) 0.93
The intrathecal CD163-haptoglobin-hemoglobin scavenging system in subarachnoid hemorrhage. J Neurochem (2012) 0.93
Morphology and physiology of primate M- and P-cells. Prog Brain Res (2004) 0.92
Blood-derived dendritic cells in an acute brain injury. J Neuroimmunol (2005) 0.92
Differential induction of interleukin-1beta and tumour necrosis factor-alpha may account for specific patterns of leukocyte recruitment in the brain. Brain Res (2002) 0.90
Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152). J Mol Med (Berl) (2004) 0.90
Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation. Eur J Neurosci (2005) 0.90
MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes. Neurobiol Dis (2007) 0.89
Modification of microglia function protects from lesion-induced neuronal alterations and promotes sprouting in the hippocampus. FASEB J (2003) 0.89
A double dissociation between the effects of sub-pyrogenic systemic inflammation and hippocampal lesions on learning. Behav Brain Res (2009) 0.88
Brain region specific pre-synaptic and post-synaptic degeneration are early components of neuropathology in prion disease. PLoS One (2013) 0.88
Fcγ receptor upregulation is associated with immune complex inflammation in the mouse retina and early age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 0.87